Avantect Test for Pancreatic Cancer Detection

Pancreatic cancer is a silent disease, usually detected in advanced stages.

These tumors are generally resistant to chemotherapy, and there are currently no other effective treatment options for these patients.

Early detection is therefore essential to make treatment more effective and improve survival rates for these patients.

The Avantect test for pancreatic cancer detection is a non-invasive blood test based on circulating tumor DNA that has the potential to detect pancreatic cancer at an early stage, with the potential to improve patient outcomes in both the short and long term.